Your browser doesn't support javascript.
loading
Detección de Nuevas Tecnologías Sanitarias Para Mejorar el Control Metabólico de Pacientes Con Diabetes Tipo 2 Atendidos en el Programa de Salud Cardiovascular de Chile.
Baeza, Mauricio; Sáenz-Ravello, Gustavo; Cuadrado, Cristóbal.
Afiliação
  • Baeza M; Programa de Doctorado en Salud Pública, Universidad de Chile, Santiago, Chile; Escuela de Salud Pública, Universidad de Chile, Santiago, Chile; Facultad de Odontología, Universidad de Chile, Santiago, Chile.
  • Sáenz-Ravello G; Facultad de Odontología, Universidad de Chile, Santiago, Chile.
  • Cuadrado C; Escuela de Salud Pública, Universidad de Chile, Santiago, Chile; Centre for Health Economics, University of York, York, England, UK. Electronic address: ccuadrado@uchile.cl.
Value Health Reg Issues ; 31: 81-92, 2022 Sep.
Article em En | MEDLINE | ID: mdl-35568012
OBJECTIVES: In Chile, > 900,000 people with type 2 diabetes mellitus (DM2) are controlled in the Cardiovascular Health Program (PSCV). Even though the PSCV includes a set of interventions for the control of patients with DM2, the results are still insufficient, generating a high human, economic, and social cost. This study aimed to identify and select new health technologies for the control of patients with DM2 not currently incorporated into the PSCV to be proposed as candidates for an economic evaluation in the Chilean context. METHODS: For the identification of new health technologies, consultations with key informants and an umbrella review of updated scientific evidence were used as sources of information. In a second step, selection among those technologies was conducted based on the effectiveness of the intervention, target population, nature of the intervention, and international evidence of cost-effectiveness antecedents. RESULTS: Key informants identified 12 candidate health technologies not currently incorporated into the PSCV. From the umbrella review, an additional 9 health technologies were identified that were not identified by the key informants. Of the 21 new health technologies identified, finally 8 health technologies were selected (structured group education, pedometer use, periodontal treatment, cognitive-behavioral therapy, telemonitoring, sitagliptin, canagliflozin, and insulin degludec). CONCLUSIONS: The health technologies detected have a high potential to be studied through economic evaluations that allow guiding decision making around improving the health outcomes of patients with DM2 in Chile.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Limite: Humans País/Região como assunto: America do sul / Chile Idioma: En Revista: Value Health Reg Issues Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Chile País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Limite: Humans País/Região como assunto: America do sul / Chile Idioma: En Revista: Value Health Reg Issues Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Chile País de publicação: Estados Unidos